New Variations on the Theme of Gold(III) C∧N∧N Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization

被引:30
作者
Carboni, Silvia [1 ,2 ]
Zucca, Antonio [1 ,2 ]
Stoccoro, Sergio [1 ]
Maiore, Laura [1 ]
Arca, Massimiliano [3 ]
Ortu, Fabrizio [4 ]
Artner, Christian [5 ,6 ]
Keppler, Bernhard K. [5 ,6 ]
Meier-Menches, Samuel M. [6 ,7 ]
Casini, Angela [8 ]
Cinellu, Maria Agostina [1 ,2 ]
机构
[1] Univ Sassari, Dipartimento Chim & Farm, Via Vienna 2, I-07100 Sassari, Italy
[2] CIRCC, I-70126 Bari, Italy
[3] Univ Cagliari, Dipartimento Sci Chim & Geol, SS 554 Bivio Sestu, I-09042 Cagliari, Italy
[4] Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England
[5] Univ Vienna, Inst Inorgan Chem, Waehringer Str 42, A-1090 Vienna, Austria
[6] Univ Vienna, Res Cluster Translat Canc Therapy Res, A-1090 Vienna, Austria
[7] Univ Vienna, Dept Analyt Chem, Waehringer Str 38, A-1090 Vienna, Austria
[8] Cardiff Univ, Sch Chem, Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales
关键词
SOLUTION CHEMISTRY; ORGANOGOLD(III) COMPOUNDS; BINDING; CYTOTOXICITY; DERIVATIVES; CYSTEINE; LIGAND; FUTURE; GOLD; DRUG;
D O I
10.1021/acs.inorgchem.8b02604
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
A series of novel (C<^>N<^>N) cyclometalated Au complexes of general formula [Au(bipy(dmb)-H)X][PF6] (bipya(dmb)-H = C<^>N<^>N cyclometalated dimethylbenzy1)-2,2'-bipyridine) were prepared with a range of anionic ligands X in the fourth coordination position, featuring C (alkynyl)-, N-, 0-, or S-donor atoms. The X ligands are varied in nature and include three coumarins, 4-ethynylaniline, saccharine, and thio-beta-D-glucose tetraacetate, the tripeptide glutathione (GSH), and a coumarinsubstituted amide derived from 4-ethynylaniline. The gold(I) complex [Au-(C(2)ArNHCOQ)(PPh3)] (HC(2)ArNHCOQ = N-(4-ethynylphenyl)-2-oxo-2H-chromene-3-carboxamide) was also prepared for comparison. The new compounds were fully characterized by means of analytical techniques, including NMR, absorption, and emission spectroscopy. The crystal structures of three cyclometalated Aunt complexes and of the Au-I derivative were solved by single-crystal X-ray diffraction. The antiproliferative activity of the new Au-III cyclometalated derivatives was evaluated against cancer cells in vitro. According to the obtained results, only complexes 3-PF6 and 5-PF6, featuring coumarins as ancillary ligands and endowed with high redox stability in solution, display antiproliferative effects, with 5-PF6 being the most potent, while all of the others are scarcely active to nonactive in the selected cell lines. In order to study the reactivity of the compounds with biomolecules, the interaction of complexes 3-PF6 and 5-PF6 with the protein cytochrome c and the amino acids cysteine and histidine was analyzed by electrospray ionization mass spectrometry (ESI MS), showing adduct formation only with Cys after at least 1 h incubation. Furthermore, the parent hydroxo complex [Au(bipy(dmb)-H)(OH)][PF6] (1OH-PF6) was investigated in a competitive assay to determine the protein vs oligonucleotide binding preferences by capillary zone electrophoresis (CZE) coupled to ESI-MS. Of note, the compound was found to selectively form adducts with the oligonucleotide over the protein upon ligand exchange with the hydroxido ligand. Adduct formation occurred within the first 10 min of incubation, demonstrating the preference of 1OH-PF6 for nucleotides in this setup. Overall, the obtained results point toward the possibility to selectively target DNA with gold(III) organometallics.
引用
收藏
页码:14852 / 14865
页数:14
相关论文
共 52 条
  • [1] [Anonymous], 2015, CRYSILLIS PRO
  • [2] [Anonymous], 2004, POV-Ray
  • [3] Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay
    Artner, Christian
    Holtkamp, Hannah U.
    Hartinger, Christian G.
    Meier-Menches, Samuel M.
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2017, 177 : 322 - 327
  • [4] DNA or protein? Capillary zone electrophoresismass spectrometry rapidly elucidates metallodrug binding selectivity
    Artner, Christian
    Holtkamp, Hannah U.
    Kandioller, Wolfgang
    Hartinger, Christian G.
    Meier-Menches, Samuel M.
    Keppler, Bernhard K.
    [J]. CHEMICAL COMMUNICATIONS, 2017, 53 (57) : 8002 - 8005
  • [5] Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C∧N theme
    Bertrand, B.
    Spreckelmeyer, S.
    Bodio, E.
    Cocco, F.
    Picquet, M.
    Richard, P.
    Le Gendre, P.
    Orvig, C.
    Cinellu, M. A.
    Casini, A.
    [J]. DALTON TRANSACTIONS, 2015, 44 (26) : 11911 - 11918
  • [6] Gold(III) Complexes for Antitumor Applications: An Overview
    Bertrand, Benoit
    Williams, Morwen R. M.
    Bochmann, Manfred
    [J]. CHEMISTRY-A EUROPEAN JOURNAL, 2018, 24 (46) : 11840 - 11851
  • [7] Cytotoxicity of Pyrazine-Based Cyclometalated (C∧NPZ∧C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties
    Bertrand, Benoit
    Fernandez-Cestau, Julio
    Angulo, Jesus
    Cominetti, Marco M. D.
    Waller, Zoe A. E.
    Searcey, Mark
    O'Connell, Maria A.
    Bochmann, Manfred
    [J]. INORGANIC CHEMISTRY, 2017, 56 (10) : 5728 - 5740
  • [8] A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds
    Bertrand, Benoit
    Casini, Angela
    [J]. DALTON TRANSACTIONS, 2014, 43 (11) : 4209 - 4219
  • [9] Luminescent cyclometalated gold(III) complexes
    Bronner, Catherine
    Wenger, Oliver S.
    [J]. DALTON TRANSACTIONS, 2011, 40 (46) : 12409 - 12420
  • [10] Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes
    Buckley, RG
    Elsome, AM
    Fricker, SP
    Henderson, GR
    Theobald, BRC
    Parish, RV
    Howe, BP
    Kelland, LR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (26) : 5208 - 5214